FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376642783> ?p ?o ?g. }

• W4376642783 abstract "Aims To investigate the hypothesis that weight loss with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide alone would lead to a greater reduction in the proportion of fat to lean tissue mass when compared to caloric restriction (CR) alone, as well as when compared to treatment with sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, that also enhances GLP-1 activity - to determine the independent effects of each treatment. Methods A total of 88 adults with obesity and prediabetes were randomized to 14 weeks of intervention with CR (−390 kcal/d), liraglutide (1.8 mg/d), or the dipeptidyl peptidase-4 inhibitor sitagliptin (100 mg/d) as a weight-neutral comparator. Changes between groups in appetite and hunger ratings measured via visual analogue scales, dietary intakes, body weight, body composition via dual energy x-ray absorptiometry, and resting energy expenditure via indirect calorimetry were assessed using the Kruskal-Wallis test or Pearson's chi-squared test. Results Weight loss ≥5% of baseline body weight occurred in 44% of participants in the CR group, 22% of the liraglutide group and 5% of the sitagliptin group (p = 0.02). The ratio of fat to lean mass decreased by 6.5% in the CR group, 2.2% in the liraglutide group, and 0% in the sitagliptin group (p = 0.02). Visceral fat reduced by 9.5% in the CR group, 4.8% in the liraglutide group, and 0% in the sitagliptin group (p = 0.04). A spontaneous reduction in dietary simple carbohydrates in the CR group was associated with improved homeostatic model assessment of insulin resistance score (HOMA-IR). Conclusions Although both liraglutide and CR are valuable strategies for cardiometabolic risk reduction, CR was associated with greater weight loss and more favourable improvements in body composition than treatment with liraglutide alone. Differences in the response to each of these interventions enables patients to be stratified to the most optimal intervention for their personal risk factors." @default.
• W4376642783 created "2023-05-17" @default.
• W4376642783 creator A5005616772 @default.
• W4376642783 creator A5024781925 @default.
• W4376642783 creator A5036650201 @default.
• W4376642783 creator A5055618165 @default.
• W4376642783 creator A5055850833 @default.
• W4376642783 creator A5059651757 @default.
• W4376642783 creator A5065836106 @default.
• W4376642783 creator A5068362253 @default.
• W4376642783 creator A5081637691 @default.
• W4376642783 creator A5090564785 @default.
• W4376642783 date "2023-05-15" @default.
• W4376642783 modified "2023-10-16" @default.
• W4376642783 title "Effect of the <scp>glucagon‐like</scp> peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes" @default.
• W4376642783 cites W1798757189 @default.
• W4376642783 cites W1968286086 @default.
• W4376642783 cites W1971524892 @default.
• W4376642783 cites W1987954357 @default.
• W4376642783 cites W2018940614 @default.
• W4376642783 cites W2028637607 @default.
• W4376642783 cites W2030795765 @default.
• W4376642783 cites W2041811148 @default.
• W4376642783 cites W2046778213 @default.
• W4376642783 cites W2053575156 @default.
• W4376642783 cites W2054008691 @default.
• W4376642783 cites W2063007022 @default.
• W4376642783 cites W2094050483 @default.
• W4376642783 cites W2101297052 @default.
• W4376642783 cites W2107797783 @default.
• W4376642783 cites W2108439170 @default.
• W4376642783 cites W2109955513 @default.
• W4376642783 cites W2119374420 @default.
• W4376642783 cites W2124620553 @default.
• W4376642783 cites W2131501155 @default.
• W4376642783 cites W2141884714 @default.
• W4376642783 cites W2142038460 @default.
• W4376642783 cites W2143952061 @default.
• W4376642783 cites W2150502418 @default.
• W4376642783 cites W2152835319 @default.
• W4376642783 cites W2163568005 @default.
• W4376642783 cites W2167607159 @default.
• W4376642783 cites W2188400457 @default.
• W4376642783 cites W2292172438 @default.
• W4376642783 cites W2425519618 @default.
• W4376642783 cites W2443999297 @default.
• W4376642783 cites W2463959854 @default.
• W4376642783 cites W2547272800 @default.
• W4376642783 cites W2558199233 @default.
• W4376642783 cites W2562747146 @default.
• W4376642783 cites W2593691145 @default.
• W4376642783 cites W2754605776 @default.
• W4376642783 cites W2786535406 @default.
• W4376642783 cites W2803591279 @default.
• W4376642783 cites W2886677972 @default.
• W4376642783 cites W2890196999 @default.
• W4376642783 cites W2930726812 @default.
• W4376642783 cites W2943046915 @default.
• W4376642783 cites W2953512018 @default.
• W4376642783 cites W2969749902 @default.
• W4376642783 cites W2982492220 @default.
• W4376642783 cites W2985631573 @default.
• W4376642783 cites W3191761156 @default.
• W4376642783 cites W4200026682 @default.
• W4376642783 cites W4200310486 @default.
• W4376642783 cites W4210242902 @default.
• W4376642783 cites W4220926409 @default.
• W4376642783 cites W4224925677 @default.
• W4376642783 cites W4307498814 @default.
• W4376642783 doi "https://doi.org/10.1111/dom.15113" @default.
• W4376642783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37188932" @default.
• W4376642783 hasPublicationYear "2023" @default.
• W4376642783 type Work @default.
• W4376642783 citedByCount "0" @default.
• W4376642783 crossrefType "journal-article" @default.
• W4376642783 hasAuthorship W4376642783A5005616772 @default.
• W4376642783 hasAuthorship W4376642783A5024781925 @default.
• W4376642783 hasAuthorship W4376642783A5036650201 @default.
• W4376642783 hasAuthorship W4376642783A5055618165 @default.
• W4376642783 hasAuthorship W4376642783A5055850833 @default.
• W4376642783 hasAuthorship W4376642783A5059651757 @default.
• W4376642783 hasAuthorship W4376642783A5065836106 @default.
• W4376642783 hasAuthorship W4376642783A5068362253 @default.
• W4376642783 hasAuthorship W4376642783A5081637691 @default.
• W4376642783 hasAuthorship W4376642783A5090564785 @default.
• W4376642783 hasConcept C120863210 @default.
• W4376642783 hasConcept C126322002 @default.
• W4376642783 hasConcept C134018914 @default.
• W4376642783 hasConcept C147583825 @default.
• W4376642783 hasConcept C170493617 @default.
• W4376642783 hasConcept C2777180221 @default.
• W4376642783 hasConcept C2778763485 @default.
• W4376642783 hasConcept C2778938600 @default.
• W4376642783 hasConcept C2779284873 @default.
• W4376642783 hasConcept C2781308992 @default.
• W4376642783 hasConcept C511355011 @default.
• W4376642783 hasConcept C544821477 @default.
• W4376642783 hasConcept C555293320 @default.
• W4376642783 hasConcept C71924100 @default.
• W4376642783 hasConceptScore W4376642783C120863210 @default.

• next